All In MedTech

Device Trial Radar · NCT06410313

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease

Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Aug 15, 2024

Primary completion

Jan 30, 2027

Study completion Feb 28, 2030

Sponsor

Lead sponsor
Medinol Ltd.Not on our public-company list
Sponsor type
Industry
First posted
May 13, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, open label, multicenter, single arm, first in human clinical study. Patients with infra-inguinal peripheral arterial disease appropriate for treatment with a femoro-popliteal stent will be enrolled. The patients will be treated with the ChampioNIR Stent System. All implanted patients will be followed up at 30 days and 6, 12, 24 and 36 months. The follow-up visits will include patency evaluation by duplex ultrasound

Conditions

  • Superficial Femoral Artery Stenosis
  • Popliteal Artery Stenosis

Interventions

  • ChampioNIR Ridaforolimus Eluting Peripheral Stent SystemDevice

    ChampioNIR implantation in Patients with Superficial Femoral Artery Disease and/or Proximal Popliteal Artery disease

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary patency of the target lesionTime frame: 6 months

1 more outcomes with a free account

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • Piedmont Healthcare, Inc.

    Atlanta, Georgia

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.